Cargando…

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells

Oleoylethanolamide (OEA), an endocannabinoid-like molecule, was revealed to modulate lipid metabolism through a peroxisome proliferator-activated receptor-α (PPAR-α) mediated mechanism. In present study, we further investigated the activities and mechanisms of OEA in ameliorating hepatic fibrosis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ling, Li, Long, Chen, Junde, Li, Lei, Zheng, Zihan, Ren, Jie, Qiu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper: Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767450/ https://www.ncbi.nlm.nih.gov/pubmed/26729705

Ejemplares similares

Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
por: Diao, Xiaotong, et al.
Publicado: (2022)

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease
por: Comerota, Michele M., et al.
Publicado: (2023)

RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis
por: Takata, Akemi, et al.
Publicado: (2017)

PPAR Gamma and Hepatic Stellate Cells
por: Hazra, Saswati, et al.
Publicado: (2004)

Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization
por: Li, Ying, et al.
Publicado: (2023)

Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
por: Decara, Juan Manuel, et al.
Publicado: (2012)

Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α
por: Zhang, Feng, et al.
Publicado: (2018)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum
por: Zhang, Feng, et al.
Publicado: (2022)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
por: Zhang, Feng, et al.
Publicado: (2014)

PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates
por: Kamata, Shotaro, et al.
Publicado: (2020)

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL
por: Fan, Angran, et al.
Publicado: (2014)

Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
por: Ying, Hanglu, et al.
Publicado: (2022)

Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection
por: Meng, Nan, et al.
Publicado: (2016)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis
por: Li, Zhiman, et al.
Publicado: (2021)

Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX
por: Chen, Zhijin, et al.
Publicado: (2017)

Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10
por: Wang, Ya-Hui, et al.
Publicado: (2017)

Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum
por: González-Portilla, Macarena, et al.
Publicado: (2023)

MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
por: Wang, Qi, et al.
Publicado: (2020)

Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway
por: Xia, Yujing, et al.
Publicado: (2020)

Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways
por: Ji, Jie, et al.
Publicado: (2021)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
por: Romano, Adele, et al.
Publicado: (2021)

Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ
por: Zhang, Zhi-hao, et al.
Publicado: (2019)

Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway
por: Yuan, Siyu, et al.
Publicado: (2021)

Endogenous Oleoylethanolamide Crystals Loaded Lipid Nanoparticles with Enhanced Hydrophobic Drug Loading Capacity for Efficient Stroke Therapy
por: Wu, Shichao, et al.
Publicado: (2021)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
por: Li, Zhiyong, et al.
Publicado: (2021)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
por: Park, Yong Joo, et al.
Publicado: (2020)

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
por: Feng, Yi, et al.
Publicado: (2016)

Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
por: Seo, Hye-Young, et al.
Publicado: (2019)

Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway
por: Liang, Lei, et al.
Publicado: (2016)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis
por: Zhang, Yuwei, et al.
Publicado: (2020)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hgiht6kbkhrk7oak4sbd0gbp6g